Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2021 Earnings

10NovExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-25.5
-16.83
-8.17
0.5

Details

Expected EPS
-14.5
Actual EPS
-15.5
Surprise EPS
-1
Surprise Percent
+6.9%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -15.5 per share for Q3 2021.

0 Comments

Share your thoughts